Original Article

• Clinical Significance of Apurinic/Apyrimidinic Endodeoxyribonuclease 1 and MicroRNA Axis in Hepatocellular Carcinoma

  Giovanna Mangiapane, Devis Pascut, Emiliano Dalla, Giulia Antoniali, Monica Degrassi, Lory Saveria Crocè, Veronica De Sanctis, Silvano Piazza, Giulia Canarutto, Claudio Tiribelli, Gianluca Tell

  
• IGF2BP3 Enhances the Growth of Hepatocellular Carcinoma Tumors by Regulating the Properties of Macrophages and CD8⁺ T Cells in the Tumor Microenvironment

  Lingyu Ma, Jiayu Jiang, Qin Si, Chong Chen, Zhaojun Duan

  
• Prognostic Performance of the China Liver Cancer Staging System in Hepatocellular Carcinoma Following Transarterial Chemoembolization

  Bin-Yan Zhong, Jian-Qiang Jiang, Jun-Hui Sun, Jin-Tao Huang, Wei-Dong Wang, Qi Wang, Wen-Bin Ding, Xiao-Li Zhu, Cai-Fang Ni

  
• Molecular Detection of FGFR2 Rearrangements in Resected Intrahepatic Cholangiocarcinomas: FISH Could Be An Ideal Method in Patients with Histological Small Duct Subtype

  Yining Zou, Kun Zhu, Yanrui Pang, Jing Han, Xin Zhang, Zhengzeng Jiang, Yufeng Huang, Wenyi Gu, Yuan Ji

  

• Proanthocyanidin Alleviates Liver Ischemia/Reperfusion Injury by Suppressing Autophagy and Apoptosis via the PPARα/PGC1α Signaling Pathway

  Zhilu Yao, Ning Liu, Hui Lin, Yingqun Zhou

  
• Fucoidan Ameliorates Ferroptosis in Ischemia-reperfusion-induced Liver Injury through Nrf2/HO-1/GPX4 Activation

  Jing-Jing Li, Wei-Qi Dai, Wen-Hui Mo, Wen-Qiang Xu, Yue-Yue Li, Chuan-Yong Guo, Xuan-Fu Xu

  
• Development and Validation of a Clinical Risk Score to Predict Immune-mediated Liver Injury Caused by Sintilimab: Assessed for Causality Using Updated RUCAM

  Caiyun Zheng, Shunmin Huang, Meimei Lin, Baohui Hong, Hengfen Dai, Jing Yang

  

• Performance of Hepatitis Delta Virus (HDV) RNA Testing for the Diagnosis of Active HDV Infection: Systematic Review and Meta-analysis

  Sisi Chen, Xiangying Zhang, Ling Xu, Yuan Tian, Zihao Fan, Yaling Cao, Zhenzhen Pan, Yao Gao, Sujun Zheng, Zhongping Duan, Mei Liu, Feng Ren

  

• A Cross-sectional Real-life Study of the Prevalence, Severity, and Determinants of Metabolic Dysfunction-associated Fatty Liver Disease in Type 2 Diabetes Patients

  Quentin Binet, Audrey Loumaye, Michel P Hermans, Nicolas Lanthier

  

Mini Review

• NASH Drug Development: Seeing the Light at the End of the Tunnel?   

  Yong Q. Chen

  

Review Article

• Integrated Multidisciplinary Management of Alcohol-associated Liver Disease   

  Malia Holbeck, Hannah Statz DeVries, Ashwani K. Singal

  
• Distinct Types of Cell Death and Implications in Liver Diseases: An Overview of Mechanisms and Application   

  Yukun Wang, Chunxia Shi, Jin Guo, Yanqiong Zhang, Zuojiong Gong

  

Guideline

• Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022)   

  Hong You, Fusheng Wang, Taisheng Li, Xiaoyuan Xu, Yameng Sun, Yuemin Nan, Guiqiang Wang, Jinlin Hou, Zhongping Duan, Lai Wei, Jidong Jia, Hui Zhuang, Chinese Society of Hepatology, Chinese Medical Association; Chinese Society of Infectious Diseases, Chinese Medical Association

  

Corrigendum

• Corrigendum: FOXO1 Alleviates Liver Ischemia-reperfusion Injury by Regulating the Th17/Treg Ratio through the AKT/Stat3/FOXO1 Pathway